Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Marksans Pharma Ltd.

Price on BSE   23 Jan,15:29 LIVE
162.55
-7.40
(-4.35%)

© 2026 Rediff.com
  • Volume :
  • 54,383.00
  • Prev Close :
  • 169.95
  • Day's H/L (Rs.) :
  • 171.75 - 162.10
  • 52wk H/L (Rs.) :
  • 276.15 - 162.05
  • Mkt Cap (Rs. Cr) :
  • 7,366.77
Price on NSE   23 Jan,15:40 LIVE
163.27
-6.53
(-3.85%)

© 2026 Rediff.com
  • Volume :
  • 1,048,718.00
  • Prev Close :
  • 169.80
  • Day's H/L (Rs.) :
  • 171.96 - 162.50
  • 52wk H/L (Rs.) :
  • 276.40 - 162.00
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Marksans Pharma Ltd.
PE Ratios
39.12
EPS (Rs.)
4.15
Sales (Rs. Cr)
320.44
Face Value (Rs.)
1
Net Profit Margin(%)
16.03
Last Bonus
-
Last Dividend(%)
80
Return on Average Equity
13.6

News for Marksans Pharma Ltd.

Unifi Capital Sells Marksans Pharma Stake
Unifi Capital sold a 1.6% stake in Marksans Pharma for nearly Rs 168 crore through an open market transaction. The shares were sold at an average price of Rs 231.50 apiece.
Jul 28, 2025 20:10
OrbiMed Sells Marksans Pharma Stake for Rs 257 Cr
OrbiMed divested a 2.27% stake in Marksans Pharma for Rs 257 crore through an open market transaction. The sale reduced OrbiMed's holding to 8.61%.
Jun 11, 2025 22:28
Pharma Stocks Sink Amid US Tariff Threat
Indian pharma stocks plunged on Wednesday following reports that the US will soon announce tariffs on pharmaceutical imports. Blue Jet Healthcare, Marksans Pharma, Wockhardt, Glenmark...
Apr 09, 2025 17:55
Pharma Stocks Plunge on Trump Tariff Threat
Pharmaceutical stocks tumbled up to 10% after reports of Trump imposing tariffs on imports. Aurobindo, Laurus, Ipca, Lupin, Biocon, and Cipla were among the hardest hit.
Apr 04, 2025 12:03
Marksans Pharma Gets USFDA Approval for Generic Allergic Rhinitis Treatment
Marksans Pharma receives USFDA approval for its generic version of Loratadine tablets, a treatment for allergic rhinitis. The approval marks a significant milestone for the company.
Nov 22, 2024 17:30

More News for Marksans Pharma Ltd. »

News for Pharmaceuticals and health care

Market Outlook: Q3 Earnings, Fed, Budget Impact
Analysts predict market movement based on Q3 earnings, US Fed decision, and the Union Budget 2026-27. Key factors examined.
Jan 25, 2026 12:09
Rupee at 92/USD: Impact on Imports, Exports & More
Rupee hits record low: How it affects imports, exports, education, travel, and remittances. Gain insights into the impact on the Indian economy.
Jan 25, 2026 11:55
Budget 2026-27: Iron Ore Beneficiation Policy Urged
Vedanta urges policy push for low-grade iron ore beneficiation in Budget 2026-27 to boost steel production and exports.
Jan 25, 2026 11:12
Skoda VW: Policy Continuity & Customs Reforms Needed
Skoda Auto Volkswagen India seeks policy continuity, infrastructure growth, and customs reforms in the Union Budget.
Jan 25, 2026 11:02
IEW 2026: Brazil Crude Oil & Shipping Contracts
IEW 2026 to see signing of Brazil crude oil import contract, ethane ship building deals. Focus on energy security and investment.
Jan 25, 2026 10:48

More News »

Top News

Market Outlook: Q3 Earnings, Fed, Budget Impact
Analysts predict market movement based on Q3 earnings, US Fed decision, and the Union Budget 2026-27. Key factors examined.
Jan 25, 2026 12:09
Jharkhand BJP Urges Police to Rescue Abducted Son
BJP urges Jharkhand Police to rescue Kairav Gandhi, son of industrialist Devang Gandhi, allegedly abducted 12 days ago from Jamshedpur.
Jan 25, 2026 12:03
Rupee at 92/USD: Impact on Imports, Exports & More
Rupee hits record low: How it affects imports, exports, education, travel, and remittances. Gain insights into the impact on the Indian economy.
Jan 25, 2026 11:55
Nalco: Green Power & Low-Carbon Aluminium
Nalco plans 200-300 MW green power with battery storage for low-carbon aluminium. Transitioning from coal to renewable energy sources.
Jan 25, 2026 11:22
Budget 2026-27: Iron Ore Beneficiation Policy Urged
Vedanta urges policy push for low-grade iron ore beneficiation in Budget 2026-27 to boost steel production and exports.
Jan 25, 2026 11:12

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com